Phenotypic and molecular characterization of OXA-48 like producing Klebsiella pneumoniae isolates in Chile
Published 2022-11-27
How to Cite
Copyright (c) 2022 Ingrid Araya, Freddy Roach-Poblete, Teresa Tapia, Paula I. Rodas, Aura Villamil, Rocio Aguero, Rodrigo Iglesias, Diego Garate, Oscar Duery, Roberto Flores, Daniel Ibañez, Jorge Fernandez, Pamela Araya, Mauro Orsini, Juan Carlos Hormazábal

This work is licensed under a Creative Commons Attribution 4.0 International License.
Abstract
Background: The appearance and spread of carbapenems-resistant Enterobacterales have generated a major impact on health care-associated infections worldwide. Recently, a Klebsiella pneumoniae outbreak expressing OXA-48 like-carbapenemases was detected in Chile, the first reported cases corresponded to hospitalized patients mainly from northern Chile. Aim: To characterize the phenotypic and genotypic profiles of antimicrobial susceptibility of 16 clinical isolates referred during May 2021 from Antofagasta and Metropolitan regions to the Reference Laboratory of Instituto de Salud Publica. Methods: Antimicrobial susceptibility of all strains was analyzed using traditional (Kirby-Bauer and epsilometry) and automated methods, and complemented with colorimetric, immunochromatographic and molecular (PCR and PFGE) techniques. As a result of the genetic characterization, blaoxa-48 and blaoxa-232 genes were detected, showing the isolates an unusual resistance profile to both carbapenems (ertapenem, imipenem, and meropenem) and cephalosporins (cefepime, cefotaxime, and ceftazidine), as well as piperacillin/tazobactam and temocillin. Two subtypes were detected by PFGE, with a predominant clone CL-Kpn-Spe-329 (93.8%), with two resistance mechanisms identified: carbapenemase and extended-spectrum b-lactamase (ESBL). Conclusion: Due to this epidemiological alert, it is essential the establishment of national guidelines for early detection, surveillance, and control of future outbreaks of OXA-48 like carbapenemases isolates.